Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportCardiovascular: Clinical Science

Trastuzumab-induced cardiac dysfunction: What happens when patients are rechallenged with the drug?

Maroun Karam, Archana Siddalingappa and Rufus Collea
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1137;
Maroun Karam
1Albany Medical Center, Radiology, Albany, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Archana Siddalingappa
1Albany Medical Center, Radiology, Albany, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rufus Collea
2Albany Medical Center, Oncology, Albany, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 50 no. supplement 2 1137

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 3, 2014.

Copyright & Usage 
© 2009 by Society of Nuclear Medicine

Author Information

  1. Maroun Karam1,
  2. Archana Siddalingappa1 and
  3. Rufus Collea2
  1. 1Albany Medical Center, Radiology, Albany, NY
  2. 2Albany Medical Center, Oncology, Albany, NY

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: February 2015 to April 2025

AbstractFullPdf
Feb 2015100
Jun 2015400
Sep 2015700
Sep 2016200
Oct 2016100
Dec 2016200
Jan 2017200
Feb 2017300
Apr 2017200
May 2017100
Jun 2017100
Oct 2017200
Nov 2017200
Mar 2018200
Apr 2018200
May 2018100
Jun 2018300
Jul 2018100
Sep 2018300
Jan 2019100
Feb 2019200
Mar 2019100
Jun 2019100
Aug 2019100
Sep 2019100
Jan 2020100
Feb 2020500
Mar 20201500
Apr 2020900
Jul 2020200
Aug 20209500
Sep 202013800
Oct 20201500
Nov 20202100
Dec 2020700
Jan 2021300
Feb 2021900
Mar 20217900
Apr 20216400
May 2021800
Jun 2021600
Jul 20211700
Aug 20213800
Sep 20211100
Oct 20211200
Nov 202110900
Dec 20213700
Jan 20228200
Feb 20222300
Mar 20221500
Apr 2022800
May 20222900
Jun 2022200
Jul 2022400
Aug 2022100
Sep 2022200
Oct 2022200
Dec 2022100
Jan 2023100
Feb 2023300
Mar 2023100
Apr 2023300
May 2023200
Jun 2023100
Jul 2023200
Aug 2023100
Sep 2023100
Oct 2023200
Nov 2023100
Dec 2023300
Jan 2024200
Feb 2024300
Mar 2024300
Apr 2024100
May 2024200
Jun 2024100
Jul 2024300
Aug 20241800
Sep 20241300
Oct 2024300
Nov 2024400
Dec 2024500
Feb 2025300
Mar 2025200
Apr 2025400
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 50, Issue supplement 2
May 2009
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Trastuzumab-induced cardiac dysfunction: What happens when patients are rechallenged with the drug?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Trastuzumab-induced cardiac dysfunction: What happens when patients are rechallenged with the drug?
Maroun Karam, Archana Siddalingappa, Rufus Collea
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1137;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Trastuzumab-induced cardiac dysfunction: What happens when patients are rechallenged with the drug?
Maroun Karam, Archana Siddalingappa, Rufus Collea
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1137;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Cardiovascular: Clinical Science

  • Comparison of the survival benefit associated with revascularization compared to medical therapy in patients with ischemic cardiomyopathy and left ventricular dysfunction undergoing [18F]FDG-PET
  • Imaging standards and quality assurance for the PET Rubidium ARMI (Alternative Radiopharmaceutical for Myocardial Imaging) multicentre trial
  • Extensive coronary calcification unmasks obstructive CAD in patients with normal SPECT MPI
Show more Cardiovascular: Clinical Science

Cardiovascular-Clinical Posters

  • Discrimination between acute and chronic dissection of the aorta using [18F]-Fluordesoxyglucose PET/CT
  • Quantification of regional myocardial blood flow using first-pass multidetector-row computed tomography compared with 201TL SPECT using adenosine triphosphate in coronary artery disease
  • Gender dependence of normal myocardial perfusion distributions using the XACT imaging system
Show more Cardiovascular-Clinical Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire